BioCentury
ARTICLE | Financial News

Genomic Health prices IPO

September 30, 2005 1:30 AM UTC

GHDX raised $60.2 million in an IPO through the sale of 5 million shares at $12, giving it a post-money valuation of $292.4 million. The deal price was at the low end of the proposed range of $12-$14....